1 / 17

The Drugs

The Drugs. Laura Duffin. Introduction. Four different series of compounds were synthesized Each compound had a phenanthridinium DNA-targeting moiety at one end Active compounds also contained an electron affinic heteroaromatic moiety at the other end. Series One.

dafydd
Download Presentation

The Drugs

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. The Drugs Laura Duffin

  2. Introduction • Four different series of compounds were synthesized • Each compound had a phenanthridinium DNA-targeting moiety at one end • Active compounds also contained an electron affinicheteroaromatic moiety at the other end

  3. Series One • First series of compounds was prepared to test whether targeting to DNA changed the relationship between radiosensitizing ability and electron affinity

  4. Series Two • Second series examined the length of the spacer arm separating the DNA binding group from the active portion of the drug

  5. Series Three • Third series was designed to examine the properties of the DNA-binding group alone

  6. Series Four • Fourth series, non-radiosensitizingbioreductive agent, and the non-bioreductive, radiosensitizingnitrotriazolemoiety

  7. Overall • Generally you tried to first attach an electrophilic spacer arm to the bioreduccible portion of the drug which was either purchased or synthesized from alicyclic precursors • Then functional group manipulation and phenanthridine was alkylated by the side chain

  8. Drugs Used • 2-Nitroimidazoles • 1-(2-Methyl-5-nitro-1H-imidazolyl)-2-bromoethane • 4- and 5-Nitroimidazoles • 5-Nitrofurans • 3-Nitropyrroles • 1-Substituted-3- and 5-nitro-1,2,4-triazoles • N3-Substrituted-3-amino-1,2,4-triazine-1,4-dioxides

  9. 2-Nitroimidazoles • Synthesis was tedious and expensive but could be scaled up to give the large quantities of the microbial agent required to make several different 2-nitroimidazole based compounds • Very good yield • The best yields and shorter reaction times were obtain when DMSO was used as a solvent

  10. 1-(2-Methyl-5-nitro-1H-imidazolyl)-2-bromoethane • Using metronidazole treated with triphenylphosphine-Br2 in acetonitrile produced a yield of 95% but the triphenylphosphine could not be separated from the product using chromatography • Could have used extremely pyrophoric triethylphosphine to give a more easily separated oxide

  11. 4- and 5-Nitroimidazoles • It was found that 4-nitroimidazoles would be the favoured tautomer in polar solvents and 5-nitroimidazole in the gas phase • Low yields were produced for both due to the decomposition caused by longer reflux periods

  12. 5-Nitrofurans • Convenient attachment of a spacer arm to the 5-nitro-2-furoic acid • Phenanthridine was then added to the arm • Good yields

  13. 3-Nitropyrroles • Several routes of synthesis were tried but all of them showed unimpressive yields

  14. Summary of Yields

  15. Summary of Yields

More Related